J&J Attempts a “Texas Two-Step”
Motley Fool Money
00:00
Johnson & Johnson's Strategic Separation and Its Implications
This chapter explores Johnson & Johnson's decision to spin off its consumer health unit into a standalone company named KenView. It discusses the implications of this restructuring for investors and the company's focus on pharmaceuticals and medical devices.
Transcript
Play full episode
